GSTC — GlobeStar Therapeutics Balance Sheet
0.000.00%
- $0.00m
- $0.37m
Annual balance sheet for GlobeStar Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.1 | 0.081 | 0.006 | 0.006 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.141 | 0.089 | 0.006 | 0.01 | 0 |
Net Property, Plant And Equipment | 0.001 | 0.001 | 0 | — | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 0.142 | 0.09 | 0.006 | 0.01 | 0 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.828 | 0.749 | 0.732 | 1.2 | 1.43 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.828 | 0.749 | 0.732 | 1.2 | 1.43 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.685 | -0.659 | -0.726 | -1.19 | -1.43 |
Total Liabilities & Shareholders' Equity | 0.142 | 0.09 | 0.006 | 0.01 | 0 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |